Hirulog-like peptide reduces restenosis and expression of tissue factor and transforming growth factor-β in carotid artery of atherosclerotic rabbits

被引:38
作者
Chen, X [1 ]
Ren, S [1 ]
Ma, MG [1 ]
Dharmalingam, S [1 ]
Lu, L [1 ]
Xue, MZ [1 ]
Ducas, J [1 ]
Shen, GX [1 ]
机构
[1] Univ Manitoba, Dept Internal Med, Winnipeg, MB R3E 3P4, Canada
基金
加拿大健康研究院;
关键词
hirulog-like peptide; restenosis; atherosclerotic rabbits; carotid artery; tissue factor; transforming growth factor-beta;
D O I
10.1016/S0021-9150(03)00105-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Restenosis is responsible to approximately 30% of long-term failure following therapeutic vascular procedures. Thrombosis plays a key role in the development of restenosis. Thrombin-specific inhibitors have been considered as one type of candidates for the prevention of restenosis. Previous studies by our group demonstrated that a novel thrombin-specific inhibitor, hirulog-like peptide (HLP), reduced balloon catheter-induced neointima formation in rat carotid arteries. The present study examined the effect of HLP on angioplasty-induced restenosis in carotid arteries of atherosclerotic rabbits. New Zealand white rabbits were subject to air desiccation of the lumen of the right carotid arteries, then received high cholesterol/fat diet for 3 weeks. The rabbits were intravenously infused with HLP (1.6 mg/(kg/h)) or saline (n = 7 per group) for 4 h started before angioplasty which dilated atherosclerotic lesions in right common carotid artery. Four weeks after the angioplasty, neointimal area, stenosis and neointima/ media ratio in injured carotid arteries were reduced in atherosclerotic rabbits treated with HLP compared to saline controls by 62, 39 and 59% (P < 0.05). The expression of tissue factor (TF) and transforming growth factor (TGF)-beta in the neointima of carotid arteries of rabbits treated with HLP was significantly weaker than saline controls (P < 0.05 or < 0.01). Activated partial thromboplastin time and bleeding time in HLP-treated rabbits were not significantly prolonged compared to controls. The results of the present study suggest that HLP may substantially reduce angioplasty-induced restenosis in atherosclerotic rabbits without increasing bleeding tendency. The inhibition on the expression of TF and TGF-beta in the neointima of the arterial wall may contribute to the preventive effect of HLP on restenosis in atherosclerotic rabbits. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 45 条
[1]  
Adgey AAJ, 1996, HAEMOSTASIS, V26, P237
[2]   Inhibition of neointima formation after experimental coronary artery stenting -: A new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost [J].
Alt, E ;
Haehnel, I ;
Beilharz, C ;
Prietzel, K ;
Preter, D ;
Stemberger, A ;
Fliedner, T ;
Erhardt, W ;
Schömig, A .
CIRCULATION, 2000, 101 (12) :1453-1458
[3]   alpha-Thrombin induces transforming growth factor-beta(1) mRNA and protein in cultured vascular smooth muscle cells via a proteolytically activated receptor [J].
Bachhuber, BG ;
Sarembock, IJ ;
Gimple, LW ;
Owens, GK .
JOURNAL OF VASCULAR RESEARCH, 1997, 34 (01) :41-48
[4]  
BARTHA K, 1993, J BIOL CHEM, V268, P421
[5]   The extracellular matrix in balloon arterial injury: A novel target for restenosis prevention [J].
Batchelor, WB ;
Robinson, R ;
Strauss, BH .
PROGRESS IN CARDIOVASCULAR DISEASES, 1998, 41 (01) :35-49
[6]   The biology of restenosis [J].
Bauters, C ;
Isner, JM .
PROGRESS IN CARDIOVASCULAR DISEASES, 1997, 40 (02) :107-116
[7]   Platelet-derived growth factor inhibits smooth muscle cell adhesion to fibronectin by ERK-dependent and ERK-independent pathways [J].
Berrou, E ;
Bryckaert, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) :39303-39309
[8]   Medical progress: Advances in coronary angioplasty [J].
Bittl, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (17) :1290-1302
[9]   A randomized comparison of bivalirudin and heparin in patients undergoing coronary angioplasty for postinfarction angina [J].
Bittl, JA ;
Feit, F .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (8B) :43P-49P
[10]   TRANSFORMING GROWTH-FACTOR-BETA IN DISEASE - THE DARK SIDE OF TISSUE-REPAIR [J].
BORDER, WA ;
RUOSLAHTI, E .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :1-7